Kurtz K*, Eibler L*, Dacek MM, Carter LM, Veach DR, Lovibond S, Reynaud E, Qureshy S, McDevitt MR, Bourne C, Monette S, Punzalan B, Khayat S, Verma S, Kesner AL, Cheung NKV, Schöder H, Gajecki L, Cheal SM, Larson SM‡, Scheinberg DA‡, Krebs S‡. Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications. *Contributed equally as first authors; ‡Contributed equally as senior authors. Theranostics 2023; 13(15):5469-5482. doi:10.7150/thno.87489. https://doi.org/10.7150/thno.87489

Dacek MM, Veach DR, Cheal SM, Carter LM, McDevitt MR, Punzalan B, Burnes Vargas D, Kubik TZ, Monette S, Santich BH, Yang G, Ouerfelli O, Kesner AL, Cheung NV, Scheinberg DA‡, Larson SM‡ and Krebs S‡. Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy Applications. ‡Contributed equally as senior authors; Bioconjug Chem. 2021 Apr 5. doi: 10.1021/acs.bioconjchem.0c00595. Online ahead of print. PMID: 33819023 https://pubmed.ncbi.nlm.nih.gov/33819023/

Krebs S, Veach DR, Carter LM, Grkovski M, Fornier M, Mauro MJ, Voss MH, Danila DC, Burnazi E, Null M, Staton K, Pressl C, Beattie BJ, Zanzonico P, Weber WA, Lyashchenko SK, Lewis JS, Larson SM, Dunphy MPS. First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET. J Nucl Med. 2020 Nov;61(11):1580-1587. doi:10.2967/jnumed.119.234864. Epub 2020 Mar 13. PMID: 32169913 https://pubmed.ncbi.nlm.nih.gov/32169913/

Krebs S, Pandit-Taskar N, Reidy D, Beattie BJ, Lyashchenko SK, Lewis JS, Bodei L, Weber WA, O’Donoghue JA. Biodistribution and radiation dose estimates for ⁶⁸Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors. Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):677-685. doi: 10.1007/s00259-018-4193-y. Epub 2018 Oct 29. PubMed PMID: 30374529; PubMed Central PMCID: PMC6447060. EANM Springer Prize 2020 - EJNMMI Best Paper 2020 https://pubmed.ncbi.nlm.nih.gov/30374529/

Krebs S, Ahad A, Carter LM, Eyquem J, Brand C, Bell M, Ponomarev V, Reiner T, Meares CF, Gottschalk S, Sadelain M, Larson SM, Weber WA. Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes. J Nucl Med. 2018 Dec;59(12):1894-1900. doi: 10.2967/jnumed.118.208041. Epub 2018 Jun 14. PubMed PMID: 29903928; PubMed Central PMCID: PMC6278895. https://pubmed.ncbi.nlm.nih.gov/29903928/

Krenciute G, Krebs S, Torres D, Wu MF, Liu H, Dotti G, Li XN, Lesniak MS, Balyasnikova IV, Gottschalk S. Characterization and Functional Analysis of scFv-based Chimeric Antigen Receptors to Redirect T Cells to IL13Rα2-positive Glioma. Mol Ther. 2016 Feb;24(2):354-363. doi: 10.1038/mt.2015.199. Epub 2015 Oct 30. PubMed PMID: 26514825; PubMed Central PMCID: PMC4817815. https://www.ncbi.nlm.nih.gov/pubmed/?term=26514825